Pharma Capsules - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharma Capsules
News and Views

Pharmaceutical Technology

During the research license period, Crucell and LFB Biotechnologies also will evaluate a joint collaboration to enhance sugar structures, described as glycosylation patterns, on recombinant antibodies using LFB's proprietary technology. Crucell's and DSM's technology platform was developed for the large-scale manufacture of biopharmaceutical products, including vaccines.


DRAXIS Names President

DRAXIS Health Inc. (Mississauga, ON, Canada) appointed Jean-Pierre Robert as president of DRAXIS Specialty Pharmaceuticals Inc. (DSP), the company's wholly owned operating subsidiary that providers sterile, nonsterile, and radiopharmaceutical products. Robert will have responsibility for DRAXIS Pharma, the contract manufacturing division of DSP, which serves clients in the pharmaceutical and biotechnology sectors.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here